Geoffrey J. Lindeman

The Royal Melbourne Hospital — Australia

Biochemistry, Genetics and Molecular Biology · Life Sciences

73h-index29.8kcitations390works5.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

BRCA gene mutations in cancer(85), Cancer Cells and Metastasis(83), Advanced Breast Cancer Therapies(70), Cancer Genomics and Diagnostics(61), Cancer Treatment and Pharmacology(52)

Publications374 total

Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer
UNC Libraries·2025Open Access
Parity and lactation induce T-cell-mediated breast cancer protection
Nature·2025· 6 citedOpen Access
617TiP Randomized phase 3 trial evaluating KAT6 inhibitor PF-07248144 plus fulvestrant in HR+HER− advanced/metastatic breast cancer after progression on CDK4/6 inhibitor-based therapy
Annals of Oncology·2025
Treatment outcomes for people with hepatitis C referred to tertiary care in Victoria, 2021–22: a retrospective observational study
The Medical Journal of Australia·2025· 1 citedOpen Access
Abstract P51: MCL-1 safeguards activated hair follicle stem cells to enable adult hair regeneration
Cancer Research·2025
Integrating breast tumor homologous recombination deficiency status to aid germline <i>BRCA1</i> and <i>BRCA2</i> variant classification
2025Open Access
Abstract P4-04-28: PF-07248144, a first-in-class KAT6 inhibitor, in patients with HR+ HER2− metastatic breast cancer: Updated results from phase 1 dose expansion study
Clinical Cancer Research·2025· 1 cited
Abstract P2-07-18: Results from PALVEN: A Phase 1b Study of Palbociclib, Letrozole and Venetoclax in ER and BCL2-Positive Metastatic Breast Cancer
Clinical Cancer Research·2025
The WinPro trial: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer.
Journal of Clinical Oncology·2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
Blood Advances·2025· 2 citedOpen Access
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesis
The EMBO Journal·2025· 4 citedOpen Access
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration
Nature Communications·2025· 4 citedOpen Access
Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesis
Cell Reports·2024· 6 citedOpen Access
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
Nature Communications·2024· 7 citedOpen Access
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia
Blood·2024· 8 citedOpen Access
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>
Journal of Clinical Oncology·2024· 15 citedOpen Access
361P PALVEN: A phase Ib study of palbociclib, letrozole and venetoclax in ER and BCL2-positive metastatic breast cancer
Annals of Oncology·2024
Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk
JAMA Network Open·2024· 6 citedOpen Access
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial
Nature Medicine·2024· 4 citedOpen Access
Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial
Nature Medicine·2024· 44 citedOpen Access
page 1 of 19Next →

Frequent Co-authors

Jane E. Visvader(41), François Vaillant(23), Gordon K. Smyth(17), Bhupinder Pal(16), Marie-Liesse Asselin-Labat(12), Nai Yang Fu(8), Anne C. Rios(7), Emma Nolan(5), Mark Shackleton(4), Natasha C. Forrest(4), Stephen B. Fox(4), Kyung-Pil Ko(4), Yunshun Chen(4), G. Bruce Mann(4), Samantha R. Oakes(4), Delphine Mérino(4), Kelsey Breslin(4), Matthew E. Ritchie(4), James R. Whittle(4), Paul R. Jamieson(4)